Episode Details

Back to Episodes
From Blind Biopsy to Precision: How MRI Changes Everything with Dr. Veeru Kasivisvanathan

From Blind Biopsy to Precision: How MRI Changes Everything with Dr. Veeru Kasivisvanathan

Episode 179 Published 3 weeks, 2 days ago
Description

What if the most common diagnostic tool in men’s health for the last 30 years was actually failing millions of patients?” For decades, the "blind" prostate biopsy was the gold standard a primitive 'hit or miss' approach that often missed aggressive tumors while over-treating harmless ones. But then came the PRECISION trial, a research earthquake that proved we’ve been doing it wrong.

In this episode, we are joined by the architect of that revolution: Professor Veeru Kasivisvanathan. A Professor of Urology at University College London and a consultant at Cleveland Clinic London, Prof. Veeru is the elite surgeon-scientist who convinced a global medical community to stop stabbing in the dark. He led the landmark trials that made MRI the mandatory gatekeeper for prostate cancer, saving countless men from unnecessary invasive procedures. If you’ve ever wondered why your doctor is ordering an MRI before a needle, or why "contrast dye" might be a thing of the past, this conversation is your roadmap.

In this episode, you’ll learn:

  • The Precision Paradigm: Why a third of men can safely avoid a biopsy altogether if their MRI is clear.
  • The Prime Trial Breakthrough: Why high-quality "biparametric" scans mean you can likely skip the Gadolinium contrast without losing accuracy.
  • The Focal Therapy Landscape: How "male lumpectomies" using HIFU and Cryotherapy are preserving potency and continence.
  • The Future of "Robotic Nerve-Sparing": How pre-operative mapping is allowing surgeons to operate with a level of visibility once thought impossible.

Timestamps:

  • 00:00 – Introduction: Is the "Blind" Biopsy Failing Men?
  • 01:30 – Meet Prof. Veeru Kasivisvanathan: The Surgeon-Scientist.
  • 04:15 – What Inspired the PRECISION Trial?
  • 08:45 – The Problem with the 30-Year "Standard of Care."
  • 12:20 – MRI as the Gatekeeper: Avoiding Unnecessary Biopsies.
  • 15:45 – The UK vs. US Healthcare Systems: Why Cost and Ethics Matter.
  • 21:00 – The PRIME Trial: Biparametric vs. Multiparametric MRI.
  • 28:30 – Is Gadolinium Contrast "Toxic"? Understanding the Risks.
  • 34:15 – MRI Quality Control: Why the Radiologist Matters More Than the Machine.
  • 40:30 – Genomic Biomarkers vs. Imaging: Do We Need Both?
  • 44:45 – Treatment Paradigms: Focal Therapy (HIFU/Cryo) explained.
  • 49:15 – When to Choose a Robotic Prostatectomy Over Focal Therapy.
  • 53:00 – How to Find Prof. Veeru and Closing Thoughts.

Key Resources Mentioned:

  • Prof. Veeru’s Profile: University College London (UCL) & Cleveland Clinic London.
  • The PRECISION Trial: Published in the New England Journal of Medicine.
  • The BURST Research Collaborative: A global network of 30,000+ patients.

___________________________________

🌱 Partner Offers

ProLon 5-Day Fasting Mimicking Diet — Enjoy fasting benefits with food. Supports cellular renewal, metabolic health, and fat loss. Special offer for our listeners: Get the ProLon kit for $148 → https://bit.ly/3TVehAx

AG1 by Athletic Greens — 75 high-quality vitamins, minerals, probiotics, and adaptogens in one daily scoop. Supports gut health, immunity, energy, and focus. Try it here → https://bit.ly/3mA2tVV

___

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us